Esophageal cancer in China: practice and research in the new era
Hongcheng Zhu,Xiao Ma,Ting Ye,Honggang Wang,Zezhou Wang,Qi Liu,Kuaile Zhao
DOI: https://doi.org/10.1002/ijc.34301
2022-09-26
International Journal of Cancer
Abstract:China, as the one of the largest developing countries in the world and with about one‐fifth of the global population, is bearing an increasing burden on health from cancer. In the area of esophageal cancer (EC), China accounts for more than 50% of the global cases, with this disease being a particularly worse for those in disadvantaged populations. Along with China's socioeconomic condition, the epidemiology, diagnosis, therapeutics, and research of this disease have developed throughout the 21st century. In the current review, existing control measures for EC in China are outlined, including the incidence, mortality, screening, clinical diagnosis, multidisciplinary treatment, and research landscape. The diseases and treatments of EC in China are very different from those in some other parts of the world, especially Western countries. Core measures that could contribute to the prevention of EC and improve clinical outcomes in patients of less developed countries and beyond are recommended. International cooperation among academia, government and industry is especially warranted in global EC control.
oncology